Bo Cao

1.9k total citations
40 papers, 1.3k citations indexed

About

Bo Cao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bo Cao has authored 40 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bo Cao's work include Cancer-related Molecular Pathways (10 papers), Ubiquitin and proteasome pathways (8 papers) and Prostate Cancer Treatment and Research (7 papers). Bo Cao is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Ubiquitin and proteasome pathways (8 papers) and Prostate Cancer Treatment and Research (7 papers). Bo Cao collaborates with scholars based in China, United States and South Korea. Bo Cao's co-authors include Hua Lu, Xiang Zhou, Shelya X. Zeng, Yan Dong, Peng Liao, Oliver Sartor, Yanfeng Qi, Andrew J. Boydston, Zhan Yang and Duo Xu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Bo Cao

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bo Cao China	20	747	371	277	267	128	40	1.3k
Weibo Xu China	20	576 0.8×	181 0.5×	142 0.5×	322 1.2×	151 1.2×	52	1.2k
Yundong He China	17	649 0.9×	375 1.0×	236 0.9×	264 1.0×	48 0.4×	29	1.0k
Robert D. Bruno United States	20	450 0.6×	211 0.6×	508 1.8×	167 0.6×	136 1.1×	34	1.4k
Valeria Carina Italy	24	724 1.0×	75 0.2×	212 0.8×	419 1.6×	72 0.6×	34	1.3k
Xiaohong Lü China	23	640 0.9×	116 0.3×	201 0.7×	231 0.9×	31 0.2×	48	1.2k
Yao Dai United States	20	758 1.0×	153 0.4×	300 1.1×	268 1.0×	12 0.1×	49	1.3k
Shuhong Wu China	27	1.1k 1.4×	167 0.5×	499 1.8×	307 1.1×	45 0.4×	81	1.9k
Emily Powell United States	19	523 0.7×	148 0.4×	338 1.2×	249 0.9×	26 0.2×	42	1.1k
Yezi Zhu United States	22	1.0k 1.4×	1.2k 3.1×	421 1.5×	764 2.9×	237 1.9×	31	2.1k
Jinfan Li China	17	452 0.6×	154 0.4×	440 1.6×	364 1.4×	22 0.2×	44	1.4k

Countries citing papers authored by Bo Cao

Since Specialization

Citations

This map shows the geographic impact of Bo Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Cao more than expected).

Fields of papers citing papers by Bo Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Cao. The network helps show where Bo Cao may publish in the future.

Co-authorship network of co-authors of Bo Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Cao. A scholar is included among the top collaborators of Bo Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Cao. Bo Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Hogyoung, et al.. (2024). Silmitasertib (CX-4945) Disrupts ERα/HSP90 Interaction and Drives Proteolysis through the Disruption of CK2β Function in Breast Cancer Cells. Cancers. 16(14). 2501–2501. 1 indexed citations

Wang, Jinlong & Bo Cao. (2024). Spinal Teratoma with Recurrent Epileptic Episodes in Adults: A Case Report. SHILAP Revista de lepidopterología. 16(1). 249–255.

Wei, Gao‐Xia, et al.. (2024). The altered volume of striatum: A neuroimaging marker of treatment in first-episode and drug-naïve schizophrenia. Schizophrenia Research Cognition. 36. 100308–100308. 1 indexed citations

Yuan, Zhen, Shuyuan Wang, Wenquan Liang, et al.. (2023). Combining neoadjuvant chemotherapy with PD-1/PD-L1 inhibitors for locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis. Frontiers in Oncology. 13. 1103320–1103320. 7 indexed citations

Chen, Zhong, Bo Cao, Andrea Edwards, Hong‐Wen Deng, & Kun Zhang. (2021). A deep imputation and inference framework for estimating personalized and race-specific causal effects of genomic alterations on PSA. Journal of Bioinformatics and Computational Biology. 19(4). 2150016–2150016. 4 indexed citations

Liao, Peng, Bo Cao, Xiang Zhou, et al.. (2020). Crotonylation at serine 46 impairs p53 activity. Biochemical and Biophysical Research Communications. 524(3). 730–735. 30 indexed citations

Jung, Ji Hoon, Hyemin Lee, Bo Cao, et al.. (2019). RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53. Oncogene. 39(5). 1031–1040. 37 indexed citations

Cao, Bo, et al.. (2019). Preparation and Properties of Fluorine-Containing Composites Modified by Polyhedral Oligomeric Silsesquioxane. Polymer Science Series A. 61(5). 681–690. 1 indexed citations

Liao, Peng, Shelya X. Zeng, Xiang Zhou, et al.. (2017). Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding. Molecular Cell. 68(6). 1134–1146.e6. 92 indexed citations

10.

Chao, Tengfei, Xiang Zhou, Bo Cao, et al.. (2016). Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53. Nature Communications. 7(1). 13755–13755. 33 indexed citations

11.

Liao, Jun‐Ming, Bo Cao, Jun Deng, et al.. (2016). TFIIS.h, a new target of p53, regulates transcription efficiency of pro-apoptotic bax gene. Scientific Reports. 6(1). 23542–23542. 13 indexed citations

12.

Cao, Bo, Kebing Wang, Jun‐Ming Liao, et al.. (2016). Inactivation of oncogenic cAMP-specific phosphodiesterase 4D by miR-139-5p in response to p53 activation. eLife. 5. 34 indexed citations

13.

Jung, Ji Hoon, Jun‐Ming Liao, Qi Zhang, et al.. (2015). Inauhzin(c) Inactivates c-Myc Independently of p53. Cancer Biology & Therapy. 16(3). 412–419. 13 indexed citations

14.

Xu, Duo, Zhan Yang, Yanfeng Qi, et al.. (2015). Androgen Receptor Splice Variants Dimerize to Transactivate Target Genes. Cancer Research. 75(17). 3663–3671. 148 indexed citations

15.

Cao, Bo, Yanfeng Qi, Yan Yang, et al.. (2014). 20(S)-Protopanaxadiol Inhibition of Progression and Growth of Castration-Resistant Prostate Cancer. PLoS ONE. 9(11). e111201–e111201. 35 indexed citations

16.

Zhou, Ting, Guobing� Li, Bo Cao, et al.. (2013). Downregulation of Mcl-1 through inhibition of translation contributes to benzyl isothiocyanate-induced cell cycle arrest and apoptosis in human leukemia cells. Cell Death and Disease. 4(2). e515–e515. 54 indexed citations

17.

Hao, Yujun, Chao Wang, Bo Cao, et al.. (2013). Gain of Interaction with IRS1 by p110α-Helical Domain Mutants Is Crucial for Their Oncogenic Functions. Cancer Cell. 23(5). 583–593. 79 indexed citations

18.

Yang, Zhan, Bo Cao, Yanfeng Qi, et al.. (2013). Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration‐resistant prostate cancer. International Journal of Cancer. 133(9). 2225–2233. 24 indexed citations

19.

Cao, Bo, Xichun Liu, Jing Li, et al.. (2012). 20(S)‐protopanaxadiol‐aglycone downregulation of the full‐length and splice variants of androgen receptor. International Journal of Cancer. 132(6). 1277–1287. 30 indexed citations

20.

Li, Jing, Bo Cao, Xichun Liu, et al.. (2011). Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer. Molecular Cancer Therapeutics. 10(8). 1346–1356. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact